Blog

  • NEA & MuleSoft: The Rise of Application Networks

    The largest transformations in the world economy have often been the result of network effects. Throughout human history, remarkable progress has been made by networks: railway networks in the 1800s; telephone networks in the 1900s; computer networks in the 1980s; internet networks in the 1990s; and social networks in the 2000s. Networks are so powerful because every new node within a network increases the value of the entire network since the data and capabilities of that new node are…

  • You Should Make an App for That

    I remember listening skeptically to a talk at MIT by a young Mitch Kapor describing how he was going to take on VisiCalc with an even better “graphical spreadsheet” that was going to be so fast and expressive that people would go beyond way bookkeeping and “build really interesting models and do all kinds of business analysis.” It was late 1981—IBM had just introduced its first PC to compete with the Apple II—and just a few months later, Mitch and Jonathan…

  • True Partnership: Our Approach to Healthcare Innovation and Company Building

    NEA will invest more than $1.25B in healthcare companies in the next three years. Here's what you should know.  As a global, diversified VC firm with more than $20B in committed capital, we believe that size confers some distinct advantages. But after almost a decade as part of NEA’s healthcare practice, I’ve learned that our scale isn’t always well understood. The breadth of our activity can obfuscate the depth of our expertise. From the perspective of an…

  • Recent FDA Decisions Signal Shift, with Troubling Implications for Patients and Medical Innovation

    Drug development has always required a surfeit of intestinal fortitude. It can take hundreds of millions of dollars and a decade or more to bring a new drug to market, and each phase of development—from structuring a clinical trial to securing reimbursement from insurers—carries substantial risk. No entity plays a more central role in the process than U.S. Food and Drug Administration (FDA), which is charged with evaluating the safety and efficacy of new drugs, as well as determining…

  • Brandless:  Disrupting Everything in Consumer Packaged Goods

    “Make it simple, but significant.”  – Don Draper, Mad Men, 2010 I am excited to announce our recent investment in Brandless, a bold new consumer packaged goods (CPG) company that officially launched today.  Brandless’ mission is simple but significant: offer health-conscious products at a disruptively low price point that can’t easily be replicated by established CPG conglomerates.  Over the past several decades, consumers have grown to believe that…